PART1 and esophageal squamous cell carcinoma: In esophageal squamous cell carcinoma (ESCC), elevated levels of exosomal lncRNA prostate androgen-regulated transcript 1 (PART1) caused resistance to gefitinib by binding to miR-129 and increasing the expression of Bcl-2 [61].